Related references
Note: Only part of the references are listed.Ghrelin: From a gut hormone to a potential therapeutic target for alcohol use disorder
Mehdi Farokhnia et al.
PHYSIOLOGY & BEHAVIOR (2019)
Advances in the science and treatment of alcohol use disorder
K. Witkiewitz et al.
SCIENCE ADVANCES (2019)
Gut-brain axis and addictive disorders: A review with focus on alcohol and drugs of abuse
Elisabet Jerlhag
PHARMACOLOGY & THERAPEUTICS (2019)
Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys
Morgane Thomsen et al.
PSYCHOPHARMACOLOGY (2019)
Lateral hypothalamic GLP-1 receptors are critical for the control of food reinforcement, ingestive behavior and body weight
L. Lopez-Ferreras et al.
MOLECULAR PSYCHIATRY (2018)
Glucagon-Like Peptide-1 Receptor Signaling in the Lateral Dorsal Tegmental Nucleus Regulates Energy Balance
David J. Reiner et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Drive and Reinforcement Circuitry in the Brain: Origins, Neurotransmitters, and Projection Fields
Roy A. Wise et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Medications for alcohol use disorders: An overview
Mohammed Akbar et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Systematic Review of Combined Pharmacotherapy for the Treatment of Alcohol Use Disorder in Patients Without Comorbid Conditions
Andrew C. Naglich et al.
CNS DRUGS (2018)
Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon
Gitanjali Srivastava et al.
CURRENT OBESITY REPORTS (2018)
Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: A systematic analysis of published clinical trials
Karolin Bettge et al.
DIABETES OBESITY & METABOLISM (2017)
The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice
Morgane Thomsen et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2017)
The glucagon-like peptide 1 receptor agonist liraglutide attenuates the reinforcing properties of alcohol in rodents
Daniel Vallof et al.
ADDICTION BIOLOGY (2016)
Effects of the GLP-1 Agonist Exendin-4 on Intravenous Ethanol Self-Administration in Mice
Gunnar Sorensen et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2016)
Low incidence of anti-drug antibodies in patients with type 2 diabetes treated with once-weekly glucagon-like peptide-1 receptor agonist dulaglutide
Z. Milicevic et al.
DIABETES OBESITY & METABOLISM (2016)
GLP-1 and estrogen conjugate acts in the supramammillary nucleus to reduce food-reward and body weight
Heike Vogel et al.
NEUROPHARMACOLOGY (2016)
Chronic Toxicity and Carcinogenicity Studies of the Long-Acting GLP-1 Receptor Agonist Dulaglutide in Rodents
Richard A. Byrd et al.
ENDOCRINOLOGY (2015)
Ghrelin and GHS-R1A signaling within the ventral and laterodorsal tegmental area regulate sexual behavior in sexually naive male mice
Luna Prieto-Garcia et al.
PSYCHONEUROENDOCRINOLOGY (2015)
An Investigative Study of Pancreatic Exocrine Biomarkers, Histology, and Histomorphometry in Male Zucker Diabetic Fatty (ZDF) Rats Given Dulaglutide by Subcutaneous Injection Twice Weekly for 13 Weeks
Amy Usborne et al.
TOXICOLOGIC PATHOLOGY (2015)
Epidemiology of DSM-5 Alcohol Use Disorder Results From the National Epidemiologic Survey on Alcohol and Related Conditions III
Bridget F. Grant et al.
JAMA PSYCHIATRY (2015)
The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependence
P. Suchankova et al.
TRANSLATIONAL PSYCHIATRY (2015)
Hindbrain nucleus tractus solitarius glucagon-like peptide-1 receptor signaling reduces appetitive and motivational aspects of feeding
Amber L. Alhadeff et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2014)
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Anna Secher et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Glucagon-like peptide-1 in the rat brain: Distribution of expression and functional implication
Guibao Gu et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2013)
The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents
Emil Egecioglu et al.
PSYCHONEUROENDOCRINOLOGY (2013)
The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide
Scott E. Kanoski et al.
NEUROPHARMACOLOGY (2012)
A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes
P. Barrington et al.
DIABETES OBESITY & METABOLISM (2011)
A genetic determinant of the striatal dopamine response to alcohol in men
V. A. Ramchandani et al.
MOLECULAR PSYCHIATRY (2011)
Ghrelin increases intake of rewarding food in rodents
Emil Egecioglu et al.
ADDICTION BIOLOGY (2010)
Sex Differences in Striatal Dopamine Release in Young Adults After Oral Alcohol Challenge: A Positron Emission Tomography Imaging Study With [11C]Raclopride
Nina B. L. Urban et al.
BIOLOGICAL PSYCHIATRY (2010)
Lack of Lipotoxicity Effect on β-Cell Dysfunction in Ketosis-Prone Type 2 Diabetes
Guillermo E. Umpierrez et al.
DIABETES CARE (2010)
Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein
Wolfgang Glaesner et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2010)
Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats
Jeffrey A. Simms et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2008)
Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation
Matthew R. Hayes et al.
ENDOCRINOLOGY (2008)
The physiology of glucagon-like peptide 1
Jens Juul Holst
PHYSIOLOGICAL REVIEWS (2007)
Heterogeneous effects of alcohol on dopamine release in the striatum: A PET study
Karmen K. Yoder et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2007)
Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not
Kirsten Raun et al.
DIABETES (2007)
Sardinian alcohol-preferring and non-preferring rats show different reactivity to aversive stimuli and a similar response to a natural reward
B Leggio et al.
BRAIN RESEARCH (2003)
Drug addiction, dysregulation of reward, and allostasis
GF Koob et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Alcohol enhances characteristic releases of dopamine and serotonin in the central nucleus of the amygdala
K Yoshimoto et al.
NEUROCHEMISTRY INTERNATIONAL (2000)
Share Paper
